“沸了”！又一只翻倍

Core Viewpoint - The article highlights the emergence of new "doubling funds" in the public fund market, particularly focusing on the impressive performance of the Changcheng Pharmaceutical Industry Select fund, which has achieved a year-to-date net value growth exceeding 100% [3][5]. Group 1: Fund Performance - The Changcheng Pharmaceutical Industry Select fund, managed by Liang Furui, has reported a year-to-date net value increase of 102.52%, following the earlier success of the Huatai-PineBridge Hong Kong Advantage Select fund [3][5]. - The fund's net value has accelerated in recent trading days, with increases of 3.17%, 2.58%, and 4.10% on July 11, July 14, and July 15, respectively [5]. - Over the past six months, the fund has achieved a remarkable growth of 111.15%, leading its peers in the same category [5]. Group 2: Market Trends - The A-share and Hong Kong stock markets have shown positive trends, with the Shanghai Composite Index and the Hang Seng Index surpassing significant levels of 3,500 and 24,000 points, respectively [5]. - The innovative drug sector has been particularly strong, with an annual growth rate exceeding 36%, contributing to the rising net values of several public funds [5]. Group 3: Fund Holdings and Strategy - As of the end of Q2, the top ten holdings of the Changcheng Pharmaceutical Industry Select fund include companies such as 3SBio, Innovent Biologics, and Hotgen Biotech, with a significant focus on innovative drugs [5]. - Liang Furui indicated that the fund will continue to focus on the innovative drug sector in Q3, emphasizing overseas licensing and domestic sales expansion as key strategies [6]. Group 4: Broader Fund Performance - As of July 15, the equity fund index has recorded a year-to-date growth of 7.95%, outperforming the CSI 300 Index by over 6 percentage points [8]. - Several other funds, including the Bank of China Hong Kong Stock Connect Pharmaceutical fund, have also reported significant growth, with some exceeding 80% year-to-date [8]. - A number of actively managed equity funds have reached historical highs in net value, indicating a strong performance across the sector [9].